全文获取类型
收费全文 | 25619篇 |
免费 | 2341篇 |
国内免费 | 102篇 |
专业分类
耳鼻咽喉 | 265篇 |
儿科学 | 621篇 |
妇产科学 | 344篇 |
基础医学 | 3125篇 |
口腔科学 | 822篇 |
临床医学 | 3332篇 |
内科学 | 5477篇 |
皮肤病学 | 631篇 |
神经病学 | 1863篇 |
特种医学 | 1133篇 |
外科学 | 3556篇 |
综合类 | 477篇 |
一般理论 | 24篇 |
预防医学 | 2695篇 |
眼科学 | 366篇 |
药学 | 2006篇 |
中国医学 | 24篇 |
肿瘤学 | 1301篇 |
出版年
2021年 | 367篇 |
2020年 | 206篇 |
2019年 | 350篇 |
2018年 | 385篇 |
2017年 | 281篇 |
2016年 | 341篇 |
2015年 | 396篇 |
2014年 | 529篇 |
2013年 | 843篇 |
2012年 | 1135篇 |
2011年 | 1122篇 |
2010年 | 657篇 |
2009年 | 602篇 |
2008年 | 1041篇 |
2007年 | 1054篇 |
2006年 | 1088篇 |
2005年 | 1123篇 |
2004年 | 1028篇 |
2003年 | 972篇 |
2002年 | 976篇 |
2001年 | 985篇 |
2000年 | 1009篇 |
1999年 | 857篇 |
1998年 | 344篇 |
1997年 | 297篇 |
1996年 | 284篇 |
1995年 | 282篇 |
1994年 | 240篇 |
1993年 | 240篇 |
1992年 | 618篇 |
1991年 | 642篇 |
1990年 | 590篇 |
1989年 | 537篇 |
1988年 | 524篇 |
1987年 | 496篇 |
1986年 | 487篇 |
1985年 | 494篇 |
1984年 | 345篇 |
1983年 | 295篇 |
1982年 | 223篇 |
1981年 | 213篇 |
1979年 | 329篇 |
1978年 | 243篇 |
1977年 | 207篇 |
1976年 | 175篇 |
1974年 | 214篇 |
1973年 | 204篇 |
1972年 | 169篇 |
1971年 | 192篇 |
1970年 | 170篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs
Anthony J. Sadler Fernando J. Rossello Liang Yu James A. Deane Xiangliang Yuan Die Wang Aaron T. Irving Maria Kaparakis-Liaskos Michael P. Gantier Hangjie Ying Howard C. H. Yim Elizabeth L. Hartland Amanda J. Notini Suzan de Boer Stefan J. White Ashley Mansell Jun-Ping Liu D. Neil Watkins Steve Gerondakis Bryan R. G. Williams Dakang Xu 《Proceedings of the National Academy of Sciences of the United States of America》2015,112(5):1535-1540
92.
93.
Blok Elisabet de Mol C. Louk van der Ende Jan Hillegers Manon H. J. Althoff Robert R. Shaw Philip White Tonya 《Child psychiatry and human development》2022,53(6):1330-1339
Child Psychiatry & Human Development - Assessing stability and change of children’s psychopathology symptoms can help elucidate whether specific behaviors are transient developmental... 相似文献
94.
95.
Kim D Harrison Beverly D Hiebert Arash Panahifar Janna M Andronowski Amir M Ashique Gavin A King Terra Arnason Kurtis J Swekla Peter Pivonka David ML Cooper 《Journal of bone and mineral research》2020,35(11):2211-2228
Cortical bone porosity is intimately linked with remodeling, is of growing clinical interest, and is increasingly accessible by imaging. Thus, the potential of animal models of osteoporosis (OP) to provide a platform for studying how porosity develops and responds to interventions is tremendous. To date, rabbit models of OP have largely focused on trabecular microarchitecture or bone density; some such as ovariectomy (OVX) have uncertain efficacy and cortical porosity has not been extensively reported. Our primary objective was to characterize tibial cortical porosity in rabbit-based models of OP, including OVX, glucocorticoids (GC), and OVX + GC relative to controls (SHAM). We sought to: (i) test the hypothesis that intracortical remodeling is elevated in these models; (ii) contrast cortical remodeling and porosity in these models with that induced by parathyroid hormone (1–34; PTH); and (iii) contrast trabecular morphology in the proximal tibia across all groups. Evidence that an increase in cortical porosity occurred in all groups was observed, although this was the least robust for GC. Histomorphometric measures supported the hypothesis that remodeling rate was elevated in all groups and also revealed evidence of uncoupling of bone resorption and formation in the GC and OVX + GC groups. For trabecular bone, a pattern of loss was observed for OVX, GC, and OVX + GC groups, whereas the opposite was observed for PTH. Change in trabecular number best explained these patterns. Taken together, the findings indicated rabbit models provide a viable and varied platform for the study of OP and associated changes in cortical remodeling and porosity. Intriguingly, the evidence revealed differing effects on the cortical and trabecular envelopes for the PTH model. © 2020 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR).. 相似文献
96.
97.
98.
Gokaraju Kishan Domos Peter Aweid Osama Fisher Rachael White Andrew Van Rensburg Lee Kang Sertaz-Niel 《European journal of orthopaedic surgery & traumatology : orthopedie traumatologie》2020,30(8):1369-1376
European Journal of Orthopaedic Surgery & Traumatology - The available literature discussing optimal surgical management of Mason II and III radial head (RH) fractures without concomitant bone... 相似文献
99.
100.
H. Evin Gulbahce Sandra White Kimberly A. Herget Greg Stoddard Nicola J. Camp Saundra S. Buys Carol Sweeney 《Journal of Geriatric Oncology》2021,12(2):206-211
ObjectivesThe influence of older age at diagnosis in combination with race/ethnicity on utilization and results of the 21-gene recurrence score (RS) assay for breast cancer (BC) patients is not fully understood. Our objectives were to evaluate the utilization of RS among older women with BC, the likelihood of a high-risk RS, and factors associated with breast cancer-specific mortality (BCSM) among older patients across different races.Materials and methodsWe utilized the Surveillance, Epidemiology, and Results (SEER) database with linked RS results to evaluate women with estrogen receptor-positive BC diagnosed 2004–2015. Multivariable logistic regression was used to describe the differences in utilization of RS testing and the association of high-risk RS according to patient characteristics. The Cox proportional hazards model was used to analyze factors associated with BCSM.ResultsWe found that 20.4% (109,244/536,555) of all women ≥18 and 14.3% (33,584/235,171) of women ≥65 underwent RS testing. Non-whites had lower odds of RS testing at younger ages whereas among women ≥65 there was no significant difference. After taking into account stage and grade, being ≥65 reduced the odds of high-risk RS in all races except American Indian/Alaskan Native. Age ≥ 65 was independently associated with increased hazard BCSM. Among women ≥65 with high-risk RS, chemotherapy was associated with lower hazard of BCSM in all races.ConclusionsOlder women are less likely to be tested for RS, but also less likely to have high-risk RS. Older women with high-risk RS, when given chemotherapy have reduced BCSM across all races. 相似文献